IL-6, as an essential trigger of epithelial-to-mesenchymal transition, activates STAT3, followed by transcription of ZEB1 and production of mesenchymal-like proteins and a mesenchymal phenotype, which is utilized by carcinoma cells to promote invasion, angiogenesis, metastasis, and apoptosis. Here, IL6 is linked to carcinoma.